These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differences in mutant p53 protein stability and functional activity in teniposide-sensitive and -resistant human leukemic CEM cells. Morgan SE; Kim R; Wang PC; Bhat UG; Kusumoto H; Lu T; Beck WT Oncogene; 2000 Oct; 19(43):5010-9. PubMed ID: 11042688 [TBL] [Abstract][Full Text] [Related]
3. Increased expression of cyclin G1 and p21WAF1/CIP1 in neurons following transient forebrain ischemia: comparison with early DNA damage. van Lookeren Campagne M; Gill R J Neurosci Res; 1998 Aug; 53(3):279-96. PubMed ID: 9698156 [TBL] [Abstract][Full Text] [Related]
5. Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin. Persons DL; Yazlovitskaya EM; Pelling JC J Biol Chem; 2000 Nov; 275(46):35778-85. PubMed ID: 10958792 [TBL] [Abstract][Full Text] [Related]
6. The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel. Mitsuuchi Y; Johnson SW; Selvakumaran M; Williams SJ; Hamilton TC; Testa JR Cancer Res; 2000 Oct; 60(19):5390-4. PubMed ID: 11034077 [TBL] [Abstract][Full Text] [Related]
7. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971 [TBL] [Abstract][Full Text] [Related]
8. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin. Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878 [TBL] [Abstract][Full Text] [Related]
9. Persistent DNA damage induced by ultraviolet light inhibits p21waf1 and bax expression: implications for DNA repair, UV sensitivity and the induction of apoptosis. McKay BC; Ljungman M; Rainbow AJ Oncogene; 1998 Aug; 17(5):545-55. PubMed ID: 9704920 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the chemosensitivity of head and neck cancer cells based on the diverse function of mutated-p53. Shinagawa Y; Kawamata H; Omotehara F; Nakashiro K; Hoque MO; Furihata T; Horiuchi H; Imai Y; Fujimori T; Fujibayashi T Int J Oncol; 2003 Feb; 22(2):383-9. PubMed ID: 12527938 [TBL] [Abstract][Full Text] [Related]
11. WAF1/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis. Kondo S; Barna BP; Kondo Y; Tanaka Y; Casey G; Liu J; Morimura T; Kaakaji R; Peterson JW; Werbel B; Barnett GH Oncogene; 1996 Sep; 13(6):1279-85. PubMed ID: 8808702 [TBL] [Abstract][Full Text] [Related]
12. Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells. Bae I; Fan S; Bhatia K; Kohn KW; Fornace AJ; O'Connor PM Cancer Res; 1995 Jun; 55(11):2387-93. PubMed ID: 7757991 [TBL] [Abstract][Full Text] [Related]
13. A DNA damage signal is required for p53 to activate gadd45. Xiao G; Chicas A; Olivier M; Taya Y; Tyagi S; Kramer FR; Bargonetti J Cancer Res; 2000 Mar; 60(6):1711-9. PubMed ID: 10749144 [TBL] [Abstract][Full Text] [Related]
14. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines. Goldwasser F; Bae I; Fornace AJ; Pommier Y Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795 [TBL] [Abstract][Full Text] [Related]
15. Cell cycle-independent regulation of p21Waf1/Cip1 and retinoblastoma protein during okadaic acid-induced apoptosis is coupled with induction of Bax protein in human breast carcinoma cells. Sheikh MS; Garcia M; Zhan Q; Liu Y; Fornace AJ Cell Growth Differ; 1996 Dec; 7(12):1599-607. PubMed ID: 8959327 [TBL] [Abstract][Full Text] [Related]
16. An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma lines. Bae I; Smith ML; Sheikh MS; Zhan Q; Scudiero DA; Friend SH; O'Connor PM; Fornace AJ Cancer Res; 1996 Feb; 56(4):840-7. PubMed ID: 8631022 [TBL] [Abstract][Full Text] [Related]
17. Prolonged wild-type p53 protein accumulation and cisplatin resistance. Yazlovitskaya EM; DeHaan RD; Persons DL Biochem Biophys Res Commun; 2001 May; 283(4):732-7. PubMed ID: 11350044 [TBL] [Abstract][Full Text] [Related]
18. Bcl-2 blocks cisplatin-induced apoptosis by suppression of ERK-mediated p53 accumulation in B104 cells. Park SA; Park HJ; Lee BI; Ahn YH; Kim SU; Choi KS Brain Res Mol Brain Res; 2001 Sep; 93(1):18-26. PubMed ID: 11532334 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of drug-induced apoptosis by antisense oligodeoxynucleotides targeted against Mdm2 and p21WAF1/CIP1. Sato N; Mizumoto K; Maehara N; Kusumoto M; Nishio S; Urashima T; Ogawa T; Tanaka M Anticancer Res; 2000; 20(2A):837-42. PubMed ID: 10810363 [TBL] [Abstract][Full Text] [Related]
20. Induction of Mdm2 and enhancement of cell survival by bFGF. Shaulian E; Resnitzky D; Shifman O; Blandino G; Amsterdam A; Yayon A; Oren M Oncogene; 1997 Nov; 15(22):2717-25. PubMed ID: 9400998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]